Fig. 2.
A: Viral loads of 14 respiratory viruses compared to SARS-CoV-2. HMPV: Human-metapneumovirus, HPIV1-4: Human Parainfluenza Viruses 1–4, InfA and B: Influenza viruses A and B; RSV: Respiratory Syncytial Virus. m represents the median, n the number of observations, and the percentage of positive test is presented. Statistical significance of viral loads of SARS-CoV-2 was assessed against the other viruses. B–C: Viral loads distribution of SARS-CoV-2 across sex and age showed comparable values among all groups. D: Initial viral loads of SARS-CoV-2 in different hospital departments. ICU first and ICU max correspond to respectively the first or highest sample recorded for patients latter admitted to the ICU. Statistical significance of viral loads was assessed against the SU samples (upper stars), and against the ICU (lower stars). E: Distribution of viral loads across different specimens. Statistical significance of viral loads was assessed against the NPS samples AS: anal swab, BAL: bronchoalveolar lavage, CSF cerebrospinal fluid, NTS: nasal-throat swab, TS: throat swab. P-values: ns: p > 0.05, ∗: p ≤ 0.05, ∗∗; p ≤ 0.01, ∗∗∗; p ≤ 0.001, ∗∗∗∗: p ≤ 0.0001.
